| 发明名称 |
COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ABIRATERONE, AND METHODS OF USE AKT |
| 摘要 |
The invention provides A combination of, a) a compound of Formula (I) or a pharmaceutically acceptable salt thereof; and b) erlotinib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer. |
| 申请公布号 |
HK1204575(A1) |
申请公布日期 |
2015.11.27 |
| 申请号 |
HK20150105215 |
申请日期 |
2015.06.01 |
| 申请人 |
GENENTECH INC. |
发明人 |
NANNINI, MICHELLE M;SAMPATH, DEEPAK D |
| 分类号 |
A61K;A61P |
主分类号 |
A61K |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
